Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rawlings

Showing results (251-260 of 312) with videos related to

Pageof 32
Sort By:
Blood|March 20, 2014
Intravenous injection of a foamy virus vector to correct canine SCID-X1Christopher R Burtner, Brian C Beard, Douglas R Kennedy, et al.
Nature Communications|June 15, 2023
SEC-seq: association of molecular signatures with antibody secretion in thousands of single human plasma cellsRene Yu-Hong Cheng, Joseph de Rutte, Cade Ellis K Ito, et al.
Molecular Therapy. Methods & Clinical Development|February 2, 2019
TALEN-Mediated Gene Editing of <i>HBG</i> in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin InductionChristopher T Lux, Sowmya Pattabhi, Mason Berger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
Targeting human plasma cells using regulated BCMA CAR T cells eliminates circulating antibodies in humanized miceYuchi Honaker, David Gruber, Chester Jacobs, et al.
Immunity|June 20, 2006
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapseTimothy S Gomez, Sean D McCarney, Esteban Carrizosa, et al.
Journal of Immunological Methods|October 18, 2020
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodiesRachael E Whaley, Sarah Ameny, Tanvi Arkatkar, et al.
Blood Vessels, Thrombosis & Hemostasis|January 29, 2026
Treatment of canine hemophilia A via intraosseous delivery of a platelet-specific factor VIII-lentiviral vectorCameron W Rementer, Chong Li, Timothy C Nichols, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2024
Blunting specific T-dependent antibody responses with engineered "decoy" B cellsRagan A Pitner, Jaime L Chao, Noelle P Dahl, et al.
Nature Communications|October 16, 2022
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivoRene Yu-Hong Cheng, King L Hung, Tingting Zhang, et al.
The Journal of Clinical Investigation|May 21, 2019
Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent mannerMarianne R Spalinger, Thomas Sb Schmidt, Marlene Schwarzfischer, et al.
Pageof 32

Showing results (251-260 of 312) with videos related to

Sort By:
Pageof 32
Blood|March 20, 2014
Intravenous injection of a foamy virus vector to correct canine SCID-X1Christopher R Burtner, Brian C Beard, Douglas R Kennedy, et al.
Nature Communications|June 15, 2023
SEC-seq: association of molecular signatures with antibody secretion in thousands of single human plasma cellsRene Yu-Hong Cheng, Joseph de Rutte, Cade Ellis K Ito, et al.
Molecular Therapy. Methods & Clinical Development|February 2, 2019
TALEN-Mediated Gene Editing of <i>HBG</i> in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin InductionChristopher T Lux, Sowmya Pattabhi, Mason Berger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
Targeting human plasma cells using regulated BCMA CAR T cells eliminates circulating antibodies in humanized miceYuchi Honaker, David Gruber, Chester Jacobs, et al.
Immunity|June 20, 2006
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapseTimothy S Gomez, Sean D McCarney, Esteban Carrizosa, et al.
Journal of Immunological Methods|October 18, 2020
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodiesRachael E Whaley, Sarah Ameny, Tanvi Arkatkar, et al.
Blood Vessels, Thrombosis & Hemostasis|January 29, 2026
Treatment of canine hemophilia A via intraosseous delivery of a platelet-specific factor VIII-lentiviral vectorCameron W Rementer, Chong Li, Timothy C Nichols, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2024
Blunting specific T-dependent antibody responses with engineered "decoy" B cellsRagan A Pitner, Jaime L Chao, Noelle P Dahl, et al.
Nature Communications|October 16, 2022
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivoRene Yu-Hong Cheng, King L Hung, Tingting Zhang, et al.
The Journal of Clinical Investigation|May 21, 2019
Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent mannerMarianne R Spalinger, Thomas Sb Schmidt, Marlene Schwarzfischer, et al.
Pageof 32